title: Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
abstract: Children with cyanotic congenital heart disease (CCHD) have complex alterations in their whole blood composition and coagulation profile due to long-standing hypoxemia. Secondary erythrocytosis is an associated physiological response intended to increase circulating red blood cells and oxygen carrying capacity. However, this response is frequently offset by an increase in whole blood viscosity that paradoxically reduces blood flow and tissue perfusion. In addition, the accompanying reduction in plasma volume leads to significant deficiencies in multiple coagulation proteins including platelets, fibrinogen and other clotting factors. On the one hand, these patients may suffer from severe hyperviscosity and subclinical 'sludging' in the peripheral vasculature with an increased risk of thrombosis. On the other hand, they are at an increased risk for postoperative hemorrhage due to a complex derangement in their hemostatic profile. Anesthesiologists caring for children with CCHD and secondary erythrocytosis need to understand the pathophysiology of these alterations and be aware of available strategies that lessen the risk of bleeding and/or thrombosis. The aim of this review is to provide an updated analysis of the systemic effects of long-standing hypoxemia in children with primary congenital heart disease with a specific focus on secondary erythrocytosis and hemostasis.
authors.affiliation: Department of Anesthesiology, University of Texas Southwestern Medical Center - Children's Health Dallas, Dallas, TX, USA.
authors.forename: Luis M
authors.initials: LM
authors.lastname: Zabala
authors.affiliation: Department of Anesthesiology, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
authors.forename: Nina A
authors.initials: NA
authors.lastname: Guzzetta
mesh_terms: D001778:Blood Coagulation Disorders / Q000150:complications* / Q000503:physiopathology; D001780:Blood Coagulation Tests; D002648:Child; D003490:Cyanosis / Q000150:complications*; D006330:Heart Defects, Congenital / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D000860:Hypoxia / Q000150:complications* / Q000503:physiopathology; D011086:Polycythemia / Q000150:complications* / Q000503:physiopathology
keywords: antifibrinolytic; blood transfusion; coagulation; congenital heart disease; heparin; neonate